ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
19
views
0
references
Top references
cited by
87
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,899
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Hydroxyurea for the treatment of sickle cell anemia.
Author(s):
Manu Platt
Publication date:
2008-03-27
Journal:
The New England journal of medicine
Keywords:
Adolescent
,
Anemia, Sickle Cell
,
drug therapy
,
physiopathology
,
Antisickling Agents
,
adverse effects
,
pharmacology
,
therapeutic use
,
Female
,
Humans
,
Hydroxyurea
,
Practice Guidelines as Topic
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Drug_transporters
Author and article information
Journal
PubMed ID::
18367739
DOI::
10.1056/NEJMct0708272
ScienceOpen disciplines:
Chemistry
Keywords:
Adolescent
,
Anemia, Sickle Cell
,
drug therapy
,
physiopathology
,
Antisickling Agents
,
adverse effects
,
pharmacology
,
therapeutic use
,
Female
,
Humans
,
Hydroxyurea
,
Practice Guidelines as Topic
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adolescent
,
Anemia, Sickle Cell
,
drug therapy
,
physiopathology
,
Antisickling Agents
,
adverse effects
,
pharmacology
,
therapeutic use
,
Female
,
Humans
,
Hydroxyurea
,
Practice Guidelines as Topic
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,899
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
Authors:
P ALLARD
,
N Alhaj
,
S Lobitz
Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera.
Authors:
Alberto Alvarez-Larrán
,
Arturo Pereira
,
Francisco Javier Cervantes
…
Novel electroanalysis of hydroxyurea at glassy carbon and gold electrode surfaces
Authors:
Keerti M. Naik
,
Sharanappa Nandibewoor
,
K.M. Naik
…
See all similar
Cited by
85
DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Authors:
G Lettre
,
V G Sankaran
,
M Bezerra
…
Periodic production of retinoic acid by meiotic and somatic cells coordinates four transitions in mouse spermatogenesis
Authors:
Tsutomu Endo
,
Elizaveta Freinkman
,
Dirk G de Rooij
…
Association of Variants at BCL11A and HBS1L-MYB with Hemoglobin F and Hospitalization Rates among Sickle Cell Patients in Cameroon
Authors:
Ambroise Wonkam
,
Valentina J. Ngo Bitoungui
,
Anna Vorster
…
See all cited by